Global Diabetes Clinical Trials Market Size & Outlook
Global diabetes clinical trials market, 2021-2033 (US$M)
Related Markets
Global diabetes clinical trials market highlights
- The global diabetes clinical trials market generated a revenue of USD 5,144.1 million in 2025 and is expected to reach USD 9,250.7 million by 2033.
- The market is expected to grow at a CAGR (2026 - 2033) of 7.9% by 2033.
- In terms of segment, phase iii accounted for a revenue of USD 2,928.8 million in 2025.
- Phase I is the most lucrative phase segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2025.
- Country-wise, Australia is expected to register the highest CAGR from 2026 to 2033.
Global data book summary
| Market revenue in 2025 | USD 5,144.1 million |
| Market revenue in 2033 | USD 9,250.7 million |
| Growth rate | 7.9% (CAGR from 2026 to 2033) |
| Largest segment | Phase iii |
| Fastest growing segment | Phase I |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Phase I, Phase II, Phase III, Phase IV |
Other key industry trends
- In terms of revenue, the North America accounted for 50.8% of the global diabetes clinical trials market in 2025.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
- By country, Australia is the fastest growing regional market and is projected to reach USD 230.7 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Diabetes Clinical Trials Market Scope
Diabetes Clinical Trials Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Telix Pharmaceuticals | View profile | 251-500 | Melbourne, Victoria, Australia, Oceania | http://www.telixpharma.com |
| Merck Sharp & Dohme Federal Credit Union | View profile | 51-100 | Chalfont, Pennsylvania, United States, North America | https://www.msdfcu.org |
| Parexel International Corporation | View profile | - | - | - |
| Novotech | View profile | 1001-5000 | Sydney, New South Wales, Australia, Oceania | http://www.novotech-cro.com/ |
| Syneos Health | View profile | 1001-5000 | Morrisville, North Carolina, United States, North America | https://www.syneoshealth.com/ |
| IQVIA Holdings Inc | View profile | 87000 | 2400 Ellis Road, Durham, NC, United States, 27703 | https://www.iqvia.com |
| Icon PLC | View profile | 41150 | South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 | https://www.iconplc.com |
| Novo Nordisk A/S ADR | View profile | 66015 | Novo Alle 1, Bagsvaerd, Denmark, 2880 | https://www.novonordisk.com |
| Eli Lilly and Co | View profile | 43000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | https://www.lilly.com |
| Labcorp Holdings Inc | View profile | 67000 | 358 South Main Street, Burlington, NC, United States, 27215 | https://www.labcorp.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
Global diabetes clinical trials market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to diabetes clinical trials market will help companies and investors design strategic landscapes.
Phase iii was the largest segment with a revenue share of 56.94% in 2025. Horizon Databook has segmented the Global diabetes clinical trials market based on phase i, phase ii, phase iii, phase iv covering the revenue growth of each sub-segment from 2021 to 2033.
- Global Diabetes Clinical Trials Phase Outlook (Revenue, USD Million, 2021-2033)
- Phase I
- Phase II
- Phase III
- Phase IV
- Global Diabetes Clinical Trials Study Design Outlook (Revenue, USD Million, 2021-2033)
- Interventional Trials
- Observational Trials
- Expanded Access Trials
- Global Diabetes Clinical Trials Indication Outlook (Revenue, USD Million, 2021-2033)
- Type 2 Diabetes Mellitus (T2DM)
- Type 1 Diabetes Mellitus (T1DM)
- Gestational Diabetes
- Others
- Global Diabetes Clinical Trials Service Outlook (Revenue, USD Million, 2021-2033)
- Protocol Designing
- Site Identification
- Patient Recruitment
- Laboratory Services
- Analytical Testing Services
- Clinical Trial Data Management Services
- Others
- Global Diabetes Clinical Trials Sponsor Outlook (Revenue, USD Million, 2021-2033)
- Pharmaceutical & Biopharmaceutical Companies
- Medical Device Companies
- Others
Reasons to subscribe to Global diabetes clinical trials market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global diabetes clinical trials market databook
-
Our clientele includes a mix of diabetes clinical trials market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global diabetes clinical trials market , including forecasts for subscribers. This global databook contains high-level insights into Global diabetes clinical trials market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Global diabetes clinical trials market size, by regions, 2021-2033 (US$M)
Top 10 countries: Diabetes clinical trials market size, 2025 (US$M)
Global diabetes clinical trials market share, by phase, 2025 & 2033 (%, US$M)
Diabetes clinical trials market: Opportunity assessment by country
Global diabetes clinical trials market, by region, 2025 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
